Regulation And Legal
Novelix Pharma Reconstitutes Three Board Committees
Novelix Pharmaceuticals Ltd (BSE: 536565) reconstituted its Audit, NRC, and Stakeholders Relationship Committees effective March 30, 2026.
Post-reconstitution, Janardhan Das Kabra chairs the Audit Com
